Gonadotropin-releasing hormone antagonist administration enhances gonadotrope responsiveness at doses inadequate to suppress immunoassayable gonadotropin levels

R. T. Scott, E. H. Illions, K. D. Carey, D. Navot

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Chronic GnRH antagonist therapy produces enhanced gonadotrope responsiveness to supraphysiologic stimuli despite the lack of any measurable suppression of gonadotropin levels. This indicates that GnRH antagonists fundamentally alter gonadotrope response mechanisms without inhibiting gonadotropin release. Beyond the physiologic implications, these data may eventually impact the development of clinical protocols. Benefits could include enhancements in the endogenous gonadotropin flare during controlled ovarian hyperstimulation cycles. Additionally, proposed contraceptive protocols where GnRH antagonists are used to produce the initial inhibition in gonadotropin release and are then followed by a GnRH-a (to avoid the gonadotropin flare) may in fact produce paradoxical results.

Original languageEnglish (US)
Pages (from-to)1069-1071
Number of pages3
JournalFertility and Sterility
Volume62
Issue number5
StatePublished - 1994
Externally publishedYes

Fingerprint

Hormone Antagonists
Gonadotropins
Gonadotropin-Releasing Hormone
Menstrual Cycle
Clinical Protocols
Contraceptive Agents

Keywords

  • baboon
  • gonadotropes
  • Gonadotropin-releasing hormone
  • gonadotropin-releasing hormone antagonists
  • gonadotropins

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Gonadotropin-releasing hormone antagonist administration enhances gonadotrope responsiveness at doses inadequate to suppress immunoassayable gonadotropin levels. / Scott, R. T.; Illions, E. H.; Carey, K. D.; Navot, D.

In: Fertility and Sterility, Vol. 62, No. 5, 1994, p. 1069-1071.

Research output: Contribution to journalArticle

@article{2e02ca04bb634296b00b7a4cad556a51,
title = "Gonadotropin-releasing hormone antagonist administration enhances gonadotrope responsiveness at doses inadequate to suppress immunoassayable gonadotropin levels",
abstract = "Chronic GnRH antagonist therapy produces enhanced gonadotrope responsiveness to supraphysiologic stimuli despite the lack of any measurable suppression of gonadotropin levels. This indicates that GnRH antagonists fundamentally alter gonadotrope response mechanisms without inhibiting gonadotropin release. Beyond the physiologic implications, these data may eventually impact the development of clinical protocols. Benefits could include enhancements in the endogenous gonadotropin flare during controlled ovarian hyperstimulation cycles. Additionally, proposed contraceptive protocols where GnRH antagonists are used to produce the initial inhibition in gonadotropin release and are then followed by a GnRH-a (to avoid the gonadotropin flare) may in fact produce paradoxical results.",
keywords = "baboon, gonadotropes, Gonadotropin-releasing hormone, gonadotropin-releasing hormone antagonists, gonadotropins",
author = "Scott, {R. T.} and Illions, {E. H.} and Carey, {K. D.} and D. Navot",
year = "1994",
language = "English (US)",
volume = "62",
pages = "1069--1071",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Gonadotropin-releasing hormone antagonist administration enhances gonadotrope responsiveness at doses inadequate to suppress immunoassayable gonadotropin levels

AU - Scott, R. T.

AU - Illions, E. H.

AU - Carey, K. D.

AU - Navot, D.

PY - 1994

Y1 - 1994

N2 - Chronic GnRH antagonist therapy produces enhanced gonadotrope responsiveness to supraphysiologic stimuli despite the lack of any measurable suppression of gonadotropin levels. This indicates that GnRH antagonists fundamentally alter gonadotrope response mechanisms without inhibiting gonadotropin release. Beyond the physiologic implications, these data may eventually impact the development of clinical protocols. Benefits could include enhancements in the endogenous gonadotropin flare during controlled ovarian hyperstimulation cycles. Additionally, proposed contraceptive protocols where GnRH antagonists are used to produce the initial inhibition in gonadotropin release and are then followed by a GnRH-a (to avoid the gonadotropin flare) may in fact produce paradoxical results.

AB - Chronic GnRH antagonist therapy produces enhanced gonadotrope responsiveness to supraphysiologic stimuli despite the lack of any measurable suppression of gonadotropin levels. This indicates that GnRH antagonists fundamentally alter gonadotrope response mechanisms without inhibiting gonadotropin release. Beyond the physiologic implications, these data may eventually impact the development of clinical protocols. Benefits could include enhancements in the endogenous gonadotropin flare during controlled ovarian hyperstimulation cycles. Additionally, proposed contraceptive protocols where GnRH antagonists are used to produce the initial inhibition in gonadotropin release and are then followed by a GnRH-a (to avoid the gonadotropin flare) may in fact produce paradoxical results.

KW - baboon

KW - gonadotropes

KW - Gonadotropin-releasing hormone

KW - gonadotropin-releasing hormone antagonists

KW - gonadotropins

UR - http://www.scopus.com/inward/record.url?scp=0028007093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028007093&partnerID=8YFLogxK

M3 - Article

C2 - 7926120

AN - SCOPUS:0028007093

VL - 62

SP - 1069

EP - 1071

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 5

ER -